Dolby Laboratories DLB
$55.33 +$0.56 (+1.02%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $55.33 0.00%
Open$54.75
Prev close$54.77
Day range$54.39 – $58.10
Volume1.35M
Market cap$5.13B
P/E (TTM)20.5
Dividend yield2.60%
Fundamentals
Latest reported quarter: Q3, ended Jun 2026
Revenue$305.00M-3.3% YoY
Operating profit$38.27M-18.7% YoY
Net profit$29.21M-37.2% YoY
Diluted EPS$0.30-37.5% YoY
Free cash flow$147.67M+141.0% YoY
Operating cash flow$167.46M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin87.6%
Operating margin19.3%
Net margin16.7%
Return on equity8.7%
Return on assets7.1%
Return on invested capital8.6%
Current ratio3.19
Liabilities / assets17.9%
Cash & investments$670.05M
Total debt$37.59M
Net cash (debt)$632.46M
Free cash flow / sales25.4%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $305.00M | $395.63M | $346.71M | $1.35B | $307.02M |
| Total Operating Revenue | $305.00M | $395.63M | $346.71M | $1.35B | $307.02M |
| Cost of Revenue | $40.32M | $44.73M | $43.21M | $160.13M | $39.52M |
| Gross Profit | $264.68M | $350.90M | $303.50M | $1.19B | $267.51M |
| Operating Expense | $226.41M | $235.77M | $230.87M | $909.03M | $231.70M |
| Selling and Admin Expenses | $160.66M | $172.12M | $161.80M | $647.24M | $164.24M |
| -Selling & Marketing Expense | $85.07M | $96.16M | $91.55M | $360.71M | $90.52M |
| -General & Admin Expense | $75.59M | $75.96M | $70.24M | $286.53M | $73.72M |
| Research & Development | $65.75M | $63.65M | $69.08M | $261.79M | $67.47M |
| Operating Profit | $38.27M | $115.13M | $72.63M | $279.97M | $35.81M |
| Net Non-Operating Interest Income (Expense) | $3.45M | $5.02M | $4.12M | $15.38M | $5.06M |
| Total Other Finance Costs | -$3.45M | -$5.02M | -$4.12M | -$15.38M | -$5.06M |
| Other Income (Expense) | $2.08M | -$455,000.00 | -$5.14M | $8.14M | $803,000.00 |
| Special Income (Charges) | -$3.96M | -$2.18M | -$10.47M | -$15.01M | -$6.13M |
| -Less:Restructuring and Mergern & Acquisition | $3.96M | $2.18M | $10.47M | $15.01M | $6.13M |
| Other Non-Operating Income (Expenses) | $6.03M | $1.73M | $5.32M | $23.15M | $6.93M |
| Pretax Profit | $43.80M | $119.70M | $71.60M | $303.49M | $41.67M |
| Tax | $14.59M | $24.25M | $17.92M | $46.99M | -$7.99M |
| Net Profit | $29.21M | $95.45M | $53.68M | $256.49M | $49.65M |
| Profit from Continuing Operations | $29.21M | $95.45M | $53.68M | $256.49M | $49.65M |
| Minority Interests | $612,000.00 | $539,000.00 | $354,000.00 | $1.47M | $322,000.00 |
| Net Income to Parent Company | $28.60M | $94.92M | $53.33M | $255.02M | $49.33M |
| Net Income to Common Stockholders | $28.60M | $94.92M | $53.33M | $255.02M | $49.33M |
| Basic EPS | $0.30 | $1.00 | $0.56 | $2.66 | $0.52 |
| Diluted EPS | $0.30 | $0.99 | $0.55 | $2.62 | $0.51 |
| Dividend Per Share | $0.36 | $0.36 | $0.36 | $1.32 | $0.33 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $3.16B | $3.25B | $3.19B | $3.23B | $3.23B |
| Total Current Assets | $1.33B | $1.41B | $1.41B | $1.39B | $1.39B |
| Cash and Cash Equivalents & Short-Term Investments | $670.05M | $594.74M | $644.58M | $702.60M | $702.60M |
| -Cash and Cash Equivalents | $669.39M | $594.28M | $643.85M | $701.89M | $701.89M |
| -Short Term Investments | $652,000.00 | $460,000.00 | $739,000.00 | $703,000.00 | $703,000.00 |
| Receivables | $492.03M | $630.22M | $571.36M | $511.90M | $511.90M |
| -Accounts Receivable | $285.15M | $391.29M | $373.09M | $331.10M | $331.10M |
| -Other Receivables | $206.88M | $238.92M | $198.27M | $180.80M | $180.80M |
| Prepaid Assets | $24.98M | $27.01M | $29.88M | $28.01M | $28.01M |
| Inventory | $30.77M | $31.93M | $31.26M | $30.42M | $30.42M |
| Restricted Cash | $69.49M | $79.52M | $83.72M | $91.47M | $91.47M |
| Other Current Assets | $38.73M | $51.29M | $47.26M | $23.87M | $23.87M |
| Total Non-Current Assets | $1.83B | $1.83B | $1.78B | $1.84B | $1.84B |
| Net PPE | $501.52M | $506.60M | $502.29M | $503.81M | $503.81M |
| -Gross PPE | $1.11B | $1.12B | $1.12B | $1.11B | $1.11B |
| -Accumulated Depreciation | -$610.55M | -$609.13M | -$613.19M | -$607.92M | -$607.92M |
| Investments and Advances | $86.44M | $81.22M | $85.02M | $80.21M | $80.21M |
| Goodwill and Other Intangible Assets | $910.78M | $919.38M | $894.32M | $926.96M | $926.96M |
| -Goodwill | $528.34M | $529.67M | $530.30M | $529.90M | $529.90M |
| -Other Intangible Assets | $382.43M | $389.71M | $364.02M | $397.06M | $397.06M |
| Non-Current Deferred Assets | $213.17M | $209.32M | $214.35M | $214.36M | $214.36M |
| Other Non-Current Assets | $118.66M | $118.27M | $88.08M | $114.16M | $114.16M |
| Total Liabilities | $563.89M | $622.36M | $589.25M | $595.81M | $595.81M |
| Total Current Liabilities | $416.33M | $474.61M | $443.51M | $437.79M | $437.79M |
| Payables | $128.36M | $190.62M | $207.60M | $193.08M | $193.08M |
| -Accounts Payable | $12.47M | $20.69M | $8.67M | $17.84M | $17.84M |
| -Total Tax Payable | $0.00 | $15,000.00 | $11.21M | $8.93M | $8.93M |
| -Other Payable | $115.89M | $169.92M | $187.72M | $166.32M | $166.32M |
| Current Accrued Expenses | $151.75M | $147.39M | $108.38M | $96.36M | $96.36M |
| Short-Term Debt and Capital Lease Obligation | $9.86M | $9.87M | $10.33M | $10.38M | $10.38M |
| -Current Capital Lease Obligation | $9.86M | $9.87M | $10.33M | $10.38M | $10.38M |
| Current Deferred Liabilities | $33.59M | $38.84M | $37.09M | $31.38M | $31.38M |
| Total Non-Current Liabilities | $147.56M | $147.76M | $145.75M | $158.02M | $158.02M |
| Long Term Accounts Payable and Other Payables | $50.64M | $48.35M | $46.04M | $46.16M | $46.16M |
| Long Term Debt and Capital Lease Obligation | $37.59M | $39.83M | $30.31M | $28.49M | $28.49M |
| -Long Term Capital Lease Obligation | $37.59M | $39.83M | $30.31M | $28.49M | $28.49M |
| Non-Current Deferred Liabilities | $23.46M | $24.08M | $25.16M | $29.69M | $29.69M |
| Employee Benefits | $5.59M | $5.26M | $5.47M | $5.32M | $5.32M |
| Other Non-Current Liabilities | $30.28M | $30.23M | $38.76M | $48.37M | $48.37M |
| Total Equity | $2.59B | $2.63B | $2.60B | $2.63B | $2.63B |
| Stockholders' Equity | $2.58B | $2.62B | $2.59B | $2.62B | $2.62B |
| Capital Stock | $92,000.00 | $93,000.00 | $94,000.00 | $94,000.00 | $94,000.00 |
| -Common Stock | $92,000.00 | $93,000.00 | $94,000.00 | $94,000.00 | $94,000.00 |
| Retained Earnings | $2.60B | $2.63B | $2.60B | $2.63B | $2.63B |
| Gains/Losses Not Affecting Retained Earnings | -$15.47M | -$12.28M | -$10.78M | -$12.52M | -$12.52M |
| Minority Interests | $9.17M | $9.14M | $9.20M | $9.39M | $9.39M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $167.46M | $92.51M | $54.80M | $472.20M | $122.83M |
| Net cash flow from continuing operations | $167.46M | $92.51M | $54.80M | $472.20M | $122.83M |
| Net Income from Continuing Operations | $29.21M | $95.45M | $53.68M | $256.49M | $49.65M |
| Gain/Loss from Continuing Operations | -$5.67M | $3.34M | -$5.28M | -$707,000.00 | -$2.55M |
| Depreciation & Depletion & Amortization | $25.07M | $26.85M | $26.81M | $98.60M | $24.58M |
| Deferred Tax | -$3.67M | $5.20M | $16,000.00 | $4.99M | $14.13M |
| Other Non-Cash Items | $452,000.00 | $149,000.00 | -$1.89M | -$1.11M | -$679,000.00 |
| Change in Working Capital | $90.55M | -$72.09M | -$56.55M | -$17.01M | $6.80M |
| -Change in Receivables | $137.60M | -$61.78M | -$102.78M | -$1.78M | -$10.12M |
| -Change in Inventory | $2.66M | $2.97M | $879,000.00 | $8.02M | $4.00M |
| -Change in Prepaid Assets | $1.84M | -$30.69M | -$3.15M | $15.22M | -$12.78M |
| -Change in Payables and Accrued Expense | -$47.26M | $39.30M | $43.58M | $22.85M | $71.83M |
| -Change in Other Current Assets | -$370,000.00 | -$12.37M | -$4.81M | -$4.51M | -$2.79M |
| -Change in Other Current Liabilities | -$1.37M | $284,000.00 | -$1.48M | -$8.91M | $5.39M |
| -Change In Other Working Capital | -$2.56M | -$9.81M | $11.22M | -$47.91M | -$48.74M |
| Net cash flow from investing | -$9.79M | -$46.09M | $1.25M | -$10.59M | -$21.91M |
| Net Cash Flow from Continuing Investing Activities | -$9.79M | -$46.09M | $1.25M | -$10.59M | -$21.91M |
| Net PPE Purchase and Sale | -$14.99M | -$9.06M | -$4.63M | -$36.35M | -$16.24M |
| Net Intangibles Purchase and Sale | $5.20M | -$37.03M | $5.87M | -$5.59M | -$5.59M |
| Net Business Purchase and Sale | $0.00 | $0.00 | $0.00 | -$1.36M | $0.00 |
| Net Investment Purchase and Sale | $0.00 | – | – | $15.84M | -$75,000.00 |
| Financing Cash Flow | -$91.02M | -$99.88M | -$121.83M | -$247.24M | -$64.06M |
| Net Cash Flow from Continuing Financing Activities | -$91.02M | -$99.88M | -$121.83M | -$247.24M | -$64.06M |
| Net Common Stock Issuance | -$56.50M | -$64.99M | -$86.95M | -$118.53M | -$32.07M |
| Cash Dividends Paid | -$33.99M | -$34.34M | -$34.34M | -$126.60M | -$31.59M |
| Net Other Financing Charges | -$534,000.00 | -$559,000.00 | -$547,000.00 | -$2.11M | -$398,000.00 |
| Ending Cash Balance | $738.89M | $673.81M | $727.57M | $793.36M | $793.36M |
| Net Change in Cash | $66.66M | -$53.46M | -$65.79M | $214.37M | $36.86M |
| Beginning Cash Balance | $673.81M | $727.57M | $793.36M | $577.75M | $756.56M |
| Effect of Exchange Rate Changes | -$1.58M | -$301,000.00 | -$5,000.00 | $1.24M | -$67,000.00 |
| Free Cash Flow | $147.67M | $46.42M | $49.42M | $430.26M | $100.99M |
| Net Other Investing Changes | – | – | – | $16.88M | $0.00 |
No comments yet — be the first to weigh in on DLB.
Sign in to join the discussion.